MENS insider transactions
Jyong Biotech Ltd. (MENS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
MENS insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Jyong Biotech Ltd., latest first. Follow anyone to get their next filing.
- Wei (vivi) ZhangCFO, since April 2026
- Fu-Feng KuoCEO, Director, 10% owner, since April 2026
- Ming Tsan HsuDirector, since April 2026
- Feng-Lin HsuDirector, since April 2026
- Hung-Shu FanDirector, since April 2026
- Pang-Chieh ChiDirector, since April 2026
Recent Form 3, 4, and 5 filings for MENS
- SEC Form 3 filed by new insider Zhang Wei (Vivi)3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Kuo Fu-Feng3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Hsu Ming Tsan3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Hsu Feng-Lin3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Hsu Feng-Lin3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Fan Hung-Shu3 - Jyong Biotech Ltd. (0001954488) (Issuer)
- SEC Form 3 filed by new insider Chi Pang-Chieh3 - Jyong Biotech Ltd. (0001954488) (Issuer)